Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis.

Patti, Francesco

Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis. [electronic resource] - Expert opinion on drug metabolism & toxicology Mar 2018 - 341-352 p. digital

Publication Type: Journal Article; Review

1744-7607

10.1080/17425255.2018.1432594 doi


Animals
Antibodies, Monoclonal, Humanized--administration & dosage
Biological Availability
Daclizumab
Dose-Response Relationship, Drug
Humans
Immunoglobulin G--administration & dosage
Immunosuppressive Agents--administration & dosage
Interleukin-2 Receptor alpha Subunit--immunology
Magnetic Resonance Imaging
Medication Adherence
Multiple Sclerosis, Relapsing-Remitting--drug therapy